Medical School · Year 2 · Microbiology · includes a quiz and discussion video

Lecture 8: Anaerobic Bacteria

Unit 2.8: Microbiology

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the classification and general characteristics of anaerobes
2. Explain the pathogenesis of anaerobic infections
3. Describe Bacteroides and other gram-negative anaerobes
4. Explain gram-positive anaerobic cocci and their infections
5. Describe anaerobic gram-positive rods (non-spore-forming)
6. Explain the diagnosis and treatment of anaerobic infections

Lecture Outline

I. Overview of Anaerobic Bacteria

Anaerobic bacteria represent a diverse and clinically significant group of microorganisms defined by their inability to utilize oxygen for metabolism and their varying degrees of oxygen sensitivity. Obligate anaerobes constitute the most stringent category, representing organisms that are killed by atmospheric oxygen concentrations because they lack protective enzymes such as superoxide dismutase and catalase that neutralize toxic oxygen radicals. Aerotolerant anaerobes occupy an intermediate position, capable of surviving brief oxygen exposure but unable to use oxygen for growth, while microaerophilic organisms require reduced oxygen concentrations, typically 2-10%, for optimal growth. Facultative anaerobes demonstrate the greatest metabolic flexibility, growing readily in either the presence or absence of oxygen, and technically represent a separate category from true anaerobes despite often being discussed alongside them.

The classification of anaerobes follows traditional bacteriological criteria based on Gram staining characteristics and cellular morphology. Gram-negative anaerobic rods include clinically important genera such as Bacteroides, Prevotella, and Fusobacterium, which dominate the normal flora of various body sites and represent the most common causes of anaerobic infections. Gram-positive anaerobic rods encompass both spore-forming organisms like Clostridium and non-spore-forming genera including Actinomyces and Propionibacterium (now Cutibacterium). Anaerobic cocci include gram-positive organisms like Peptostreptococcus and Finegoldia, as well as gram-negative cocci such as Veillonella, which plays a role in oral ecology but rarely causes significant disease.

The distribution of anaerobes as normal flora follows predictable anatomical patterns closely related to oxygen availability and tissue characteristics. The oral cavity harbors abundant populations of Fusobacterium, Prevotella, and Actinomyces, particularly in gingival crevices and dental plaque where oxygen tension is low. The gastrointestinal tract, especially the colon, represents the most densely colonized site, with Bacteroides species outnumbering aerobic organisms by ratios approaching 1000:1, reflecting the extremely low oxygen tension in the distal bowel. The female genital tract contains Prevotella and Peptostreptococcus as normal constituents of vaginal flora, while the skin harbors Propionibacterium acnes within sebaceous glands where anaerobic conditions prevail.

Understanding why normally commensal anaerobes cause disease requires appreciation of the factors that disrupt normal host-microbe equilibrium. Tissue hypoxia created by trauma, ischemia, or foreign body presence establishes local conditions favorable for anaerobic growth. Mixed infections involving aerobes and anaerobes demonstrate synergistic pathogenesis, where aerobic organisms consume available oxygen and create anaerobic microenvironments permitting anaerobic proliferation. The polysaccharide capsule of organisms like Bacteroides fragilis provides antiphagocytic protection enhancing virulence when these organisms escape their normal niches. Tissue-destructive enzymes including collagenases and proteases facilitate spread through normally sterile tissues, while disruption of normal flora through antibiotics or mucosal injury permits overgrowth and translocation.

<image>Panel A: Oxygen tolerance spectrum diagram showing four bacterial categories arranged horizontally with distinct colored zones - obligate anaerobes (red zone with skull icon indicating death at atmospheric oxygen), aerotolerant anaerobes (orange zone with partial oxygen symbol), microaerophilic organisms (yellow zone labeled "2-10% O2"), and facultative anaerobes (green zone showing growth in all conditions), with representative organisms listed beneath each category. Panel B: Human body silhouette displaying normal anaerobic flora distribution at four sites - oral cavity (Fusobacterium, Prevotella, Actinomyces with zoom showing gingival crevice), colon (massive Bacteroides population with "1000:1 ratio" indicator), female genital tract (Prevotella, Peptostreptococcus in vaginal epithelium), and skin (Propionibacterium in sebaceous gland cross-section). Panel C: Four-part pathogenesis sequence showing how anaerobes cause disease - tissue trauma creating ischemic zone, aerobic bacteria consuming oxygen creating blue anaerobic microenvironment, Bacteroides capsule deflecting approaching phagocytes, and enzyme-mediated tissue destruction with expanding infection border. Panel D: Anaerobic classification tree organized by Gram stain and morphology - two main branches (Gram-negative and Gram-positive) subdividing into rods and cocci, with major genera listed at terminal branches and microscopic morphology sketches for each (Bacteroides as plump rods, Fusobacterium as spindle-shaped, Peptostreptococcus as chains of cocci).</image>

II. Clinical Features of Anaerobic Infections

The clinical recognition of anaerobic infections relies heavily on characteristic findings that reflect the unique metabolic properties of these organisms. Foul odor represents one of the most distinctive clinical clues, resulting from the production of short-chain fatty acids and other volatile metabolic byproducts including hydrogen sulfide and ammonia; this putrid smell, often described as "barnyard" or "rotten," immediately alerts clinicians to the possibility of anaerobic involvement. Gas in tissues provides another pathognomonic feature, as anaerobic metabolism produces carbon dioxide, hydrogen, and methane that accumulate in infected tissues, creating crepitus on palpation and characteristic radiolucent patterns on imaging. The association with necrotic tissue reflects the predilection of anaerobes for ischemic environments, while abscess formation represents the typical presentation of established anaerobic infection.

Additional clinical clues suggesting anaerobic infection include proximity to mucosal surfaces, reflecting the endogenous nature of most anaerobic pathogens that arise from normal flora sites. Failure of aminoglycosides to control infection strongly suggests anaerobic involvement, as these antibiotics require oxygen-dependent active transport for bacterial uptake and are completely ineffective against anaerobes. "Sterile" pus that fails to grow organisms on routine aerobic culture should prompt consideration of anaerobes, as standard culture techniques fail to recover these oxygen-sensitive organisms. The presence of sulfur granules, characteristic yellow-white particles in purulent material, specifically indicates actinomycosis and should trigger appropriate prolonged therapy.

Anaerobic infections occur at predictable anatomical sites related to the adjacent normal flora reservoirs. Dental and orofacial infections typically involve Fusobacterium, Prevotella, and Actinomyces, presenting as periodontal abscesses, Ludwig's angina, or cervicofacial actinomycosis. Pulmonary infections, particularly aspiration pneumonia, reflect introduction of oral anaerobes into the lower respiratory tract and typically involve mixed flora including Bacteroides and Peptostreptococcus. Intra-abdominal infections following bowel perforation or surgery typically involve Bacteroides fragilis and other colonic anaerobes, while pelvic infections following childbirth, abortion, or gynecologic procedures feature Prevotella and Peptostreptococcus. Brain abscesses frequently harbor mixed anaerobic flora, often including Fusobacterium.

The formation of abscesses represents the hallmark of established anaerobic infection and reflects both bacterial virulence factors and host immune responses. Abscesses are typically polymicrobial, containing mixed populations of aerobic and anaerobic organisms that act synergistically. The location in deep tissues protects the infection from atmospheric oxygen and from surface-applied antimicrobial agents. A fibrous capsule develops around the abscess as host tissues attempt to contain the infection, but this wall also prevents effective antibiotic penetration and immune cell access. The treatment implications are paramount: surgical drainage is essential for cure of anaerobic abscesses, as antibiotics alone cannot sterilize walled-off collections regardless of in vitro susceptibility. Synergistic infections demonstrate the cooperative pathogenesis between aerobes and anaerobes, exemplified by perforated appendicitis where E. coli causes early sepsis while Bacteroides leads to subsequent abscess formation.

<image>Panel A: Clinical clue infographic showing seven diagnostic indicators arranged around a central "Anaerobic Infection?" question mark - foul odor (nose icon with wavy lines), gas in tissues (X-ray showing tissue emphysema), necrotic tissue (dark necrotic wound), abscess formation (loculated fluid collection), mucosal proximity (anatomical outline), aminoglycoside failure (crossed-out antibiotic), and sulfur granules (microscopic image of yellow particles). Panel B: Human body diagram showing common anaerobic infection sites with organism lists - brain (mixed, Fusobacterium), orofacial (Fusobacterium, Prevotella, Actinomyces), pulmonary (mixed oral flora with aspiration arrow), intra-abdominal (Bacteroides fragilis, Clostridium), pelvic (Prevotella, Peptostreptococcus), and soft tissue (mixed, Clostridium). Panel C: Abscess formation cross-section showing layered structure - central necrotic core with polymicrobial population, surrounding fibrous capsule (labeled "prevents antibiotic penetration"), adjacent inflamed tissue with infiltrating neutrophils, and surgical drainage catheter demonstrating treatment principle. Panel D: Synergistic infection timeline using perforated appendicitis model - initial perforation releasing both aerobes (E. coli shown in blue) and anaerobes (Bacteroides shown in red), early phase showing E. coli bacteremia with fever spike, late phase showing Bacteroides-dominated abscess formation with encapsulated collection.</image>

III. Bacteroides fragilis Group

Bacteroides fragilis represents the most clinically important anaerobic pathogen, causing the majority of serious anaerobic infections despite constituting a relatively small proportion of the normal colonic flora. This gram-negative rod demonstrates distinctive characteristics that contribute to its pathogenicity, including a prominent polysaccharide capsule that distinguishes it from other Bacteroides species. The predominant location in the colon exposes this organism to bowel contents that may be spilled during surgical procedures, trauma, or spontaneous perforation. Notably, B. fragilis demonstrates the greatest aerotolerance among obligate anaerobes, able to survive oxygen exposure for extended periods through protective enzymes, which facilitates transmission and establishment of infection outside the anaerobic colonic environment.

The virulence of Bacteroides fragilis derives from multiple factors that enhance survival, tissue destruction, and immune evasion. The capsular polysaccharide complex represents the dominant virulence determinant, not only providing antiphagocytic protection but actively inducing abscess formation through T-cell-dependent mechanisms that trigger excessive inflammatory responses. Superoxide dismutase and catalase production explains the exceptional oxygen tolerance, permitting survival during transit from the colon to normally sterile sites. Beta-lactamase production confers intrinsic resistance to many penicillins and cephalosporins, complicating antibiotic selection. Neuraminidase and other tissue-degrading enzymes facilitate spread through peritoneal tissues and abscess wall formation. Some strains produce an enterotoxin associated with diarrheal illness, although this represents a less common clinical presentation.

Clinical infections caused by Bacteroides fragilis predominantly affect the abdominal and pelvic regions, reflecting proximity to the colonic reservoir. Intra-abdominal abscess following operative contamination or perforated viscus represents the signature infection, typically presenting days to weeks after the inciting event with fever, localized pain, and leukocytosis. Peritonitis arising from bowel perforation invariably involves B. fragilis as part of a polymicrobial infection. Pelvic abscesses complicate surgical procedures, pelvic inflammatory disease, and obstetric complications. Bacteremia with B. fragilis typically indicates a gastrointestinal or pelvic source requiring identification and control. Liver abscess may result from hematogenous seeding via the portal circulation or direct extension from intra-abdominal infection.

Treatment of Bacteroides fragilis infections requires attention to both antimicrobial selection and source control. Metronidazole remains the first-line agent, providing excellent bactericidal activity against nearly all B. fragilis isolates with favorable pharmacokinetics and tissue penetration, particularly into abscess cavities. Carbapenems offer broad-spectrum coverage including B. fragilis and are frequently employed for empiric therapy of serious intra-abdominal infections. Beta-lactam/beta-lactamase inhibitor combinations such as piperacillin-tazobactam provide effective coverage while addressing the intrinsic beta-lactamase production. Clindamycin, historically effective against B. fragilis, demonstrates increasing resistance rates that limit its empiric use. Critically, aminoglycosides, most cephalosporins, and fluoroquinolones lack reliable activity against B. fragilis and should not be used for targeted therapy. Surgical drainage remains essential for abscess cure, with antibiotics serving as adjunctive rather than definitive therapy.

<image>Panel A: Bacteroides fragilis cellular structure showing gram-negative rod morphology with prominent multilayered polysaccharide capsule (labeled "abscess-inducing"), periplasmic beta-lactamase enzymes (shown destroying penicillin molecules), and superoxide dismutase protecting against oxygen radical damage (illustrated as shield deflecting O2- ions). Panel B: Abdominal cross-section showing B. fragilis infection pathway - colon with dense Bacteroides population, perforation site with bacterial spillage, progression arrows showing peritonitis development, and resulting intra-abdominal abscess with multiloculated appearance adjacent to bowel loops. Panel C: Infection site distribution diagram showing percentages - intra-abdominal abscess (largest segment, ~40%), peritonitis (~25%), pelvic abscess (~20%), bacteremia (~10%), and liver abscess (~5%), with brief clinical scenario description for each. Panel D: Treatment algorithm flowchart - top showing effective drugs (metronidazole highlighted as first-line, carbapenems, piperacillin-tazobactam), middle showing drugs with increasing resistance (clindamycin with caution symbol), bottom showing ineffective drugs (aminoglycosides, most cephalosporins with X marks), and side panel emphasizing "Surgical Drainage Essential" with drainage catheter illustration.</image>

IV. Other Gram-Negative Anaerobes

Prevotella species represent important anaerobic pathogens with a distribution spanning oral, gastrointestinal, and genital tract normal flora. The genus includes pigmented and non-pigmented species, with Prevotella melaninogenica producing characteristic black colonies on blood agar due to hemoglobin degradation product accumulation. Clinical infections caused by Prevotella typically occur above the diaphragm, reflecting the prominence of these organisms in oral and upper respiratory tract flora; aspiration pneumonia, head and neck infections including periodontal and odontogenic abscesses, and complicated sinusitis commonly involve Prevotella species. Pelvic infections, particularly those associated with bacterial vaginosis complications, also frequently include Prevotella. Treatment follows principles similar to Bacteroides, though Prevotella species generally demonstrate greater antibiotic susceptibility with lower rates of beta-lactamase production.

Fusobacterium species are distinctive gram-negative anaerobic rods characterized by their elongated, spindle-shaped morphology with pointed ends, earning descriptions as "cigar-shaped" or "needle-like" organisms. Fusobacterium nucleatum represents the most common species, residing as normal oral flora and contributing to periodontal disease through complex biofilm interactions with other oral bacteria. Fusobacterium necrophorum, while less common in normal flora, causes the most dramatic clinical syndrome associated with this genus. The organisms produce various virulence factors including leukotoxins that kill immune cells, hemagglutinins that facilitate adherence, and lipopolysaccharide that triggers intense inflammatory responses.

Lemierre syndrome represents a life-threatening infection caused primarily by Fusobacterium necrophorum, following a characteristic clinical sequence that clinicians must recognize. The syndrome begins with pharyngitis or peritonsillar infection, typically in otherwise healthy young adults, which then extends to involve the internal jugular vein, causing septic thrombophlebitis. From this infected thrombosis, septic emboli disseminate to distant sites, most commonly the lungs where they cause multiple cavitary lesions and septic pulmonary emboli. Patients present with persistent sore throat, neck pain and swelling, rigors, and respiratory symptoms reflecting pulmonary involvement. Diagnosis requires high clinical suspicion, with imaging demonstrating internal jugular vein thrombosis and pulmonary septic emboli. Treatment involves prolonged antibiotic therapy covering anaerobes, while the role of anticoagulation remains controversial with some evidence supporting benefit in extensive thrombosis.

Porphyromonas gingivalis represents a significant periodontal pathogen, though it less commonly causes acute infections compared to Prevotella and Fusobacterium. This pigmented gram-negative anaerobe produces black colonies similar to Prevotella melaninogenica and demonstrates particular tropism for periodontal pockets where it contributes to chronic periodontitis through persistent inflammation and tissue destruction. Research has established associations between P. gingivalis colonization and systemic inflammatory conditions including atherosclerosis, rheumatoid arthritis, and possibly Alzheimer's disease, suggesting that chronic periodontal infection may have implications beyond oral health. The organism produces gingipains, cysteine proteases that degrade host tissues and immune factors, as well as fimbriae that mediate adherence to epithelial cells and other oral bacteria.

<image>Panel A: Prevotella species comparison showing two culture plates side by side - P. melaninogenica with distinctive black-pigmented colonies on blood agar (with hemoglobin degradation pathway diagram) versus non-pigmented Prevotella species with gray colonies, alongside microscopic morphology of pleomorphic gram-negative rods. Panel B: Fusobacterium morphology and pathogenesis - microscopic view showing characteristic elongated spindle-shaped rods with pointed ends ("cigar-shaped"), virulence factor diagram (leukotoxin killing neutrophil, hemagglutinin on red blood cell, LPS triggering inflammation), and periodontal pocket cross-section showing F. nucleatum in biofilm. Panel C: Lemierre syndrome clinical progression in four steps - initial pharyngitis/tonsillitis (throat illustration), extension to internal jugular vein with septic thrombophlebitis (neck cross-section showing infected thrombus), embolization pathway (blood vessel with emboli traveling), and pulmonary septic emboli creating cavitary lung lesions (chest X-ray appearance). Panel D: Porphyromonas gingivalis in periodontal disease - detailed periodontal pocket cross-section showing bacterial colonization at gingival margin, gingipain enzymes degrading collagen and immunoglobulins, inflammatory cell infiltration in adjacent tissue, and systemic dissemination pathway suggesting links to cardiovascular disease (heart icon with question mark).</image>

V. Anaerobic Gram-Positive Cocci

The taxonomy of anaerobic gram-positive cocci has undergone substantial revision, with organisms formerly classified under Peptostreptococcus now distributed among multiple genera based on molecular phylogenetic analysis. The genus Finegoldia encompasses organisms previously known as Peptostreptococcus magnus, while Parvimonas now contains the former Peptostreptococcus micra, and Anaerococcus includes the former Peptostreptococcus prevotii. Despite these taxonomic changes, clinicians often continue using "Peptostreptococcus" as a general term for anaerobic gram-positive cocci in clinical practice. These organisms appear as chains or clusters of gram-positive cocci microscopically and grow slowly under anaerobic conditions, requiring prolonged incubation for recovery.

Anaerobic gram-positive cocci constitute normal flora at multiple body sites, contributing to the complex microbial ecosystems of various mucosal surfaces. The oral cavity harbors substantial populations, particularly in gingival crevices and periodontal pockets where they participate in biofilm communities. The gastrointestinal tract contains abundant anaerobic cocci, with highest concentrations in the colon where they coexist with Bacteroides and other obligate anaerobes. The female genital tract represents another important reservoir, with these organisms contributing to normal vaginal flora and playing roles in the pathogenesis of bacterial vaginosis. Skin colonization varies among individuals but can provide a source for wound infections, particularly in areas with compromised oxygenation.

Clinical infections caused by anaerobic gram-positive cocci typically occur as components of polymicrobial processes rather than pure monoculture infections. Aspiration pneumonia frequently involves these organisms as part of mixed oral flora aspirated into the lower respiratory tract, where they contribute to lung abscess and empyema formation. Brain abscesses commonly harbor anaerobic cocci, often alongside other oral anaerobes like Fusobacterium, reflecting hematogenous or contiguous spread from oral or sinus foci. Pelvic infections including postpartum endometritis and pelvic inflammatory disease complications feature Peptostreptococcus species as frequent isolates. Synergistic necrotizing soft tissue infections involve anaerobic cocci working in concert with other bacteria to produce rapidly progressive tissue destruction.

Treatment of infections involving anaerobic gram-positive cocci benefits from the relatively broad antibiotic susceptibility profile of these organisms compared to Bacteroides. Penicillin remains effective against most strains and represents appropriate therapy when anaerobic cocci are isolated in pure culture or as the predominant pathogen. Metronidazole demonstrates excellent activity and is commonly employed when these organisms are suspected as part of mixed anaerobic infections. Clindamycin provides reliable coverage with favorable tissue penetration, making it useful for soft tissue and bone infections. Carbapenems offer the broadest coverage and are appropriate for serious polymicrobial infections where empiric therapy must cover multiple potential pathogens including anaerobic cocci.

<image>Panel A: Taxonomic reclassification diagram showing the old genus "Peptostreptococcus" branching into new genera - Finegoldia (from P. magnus), Parvimonas (from P. micra), Anaerococcus (from P. prevotii), with remaining Peptostreptococcus species, each with microscopic morphology illustration showing gram-positive cocci in chains and clusters. Panel B: Human body diagram showing normal flora distribution of anaerobic gram-positive cocci - oral cavity (gingival crevice detail), GI tract (colon cross-section showing mixed anaerobic population), female genital tract (vaginal epithelium with bacterial overlay), and skin (hair follicle colonization). Panel C: Clinical infection montage showing four infection types - aspiration pneumonia (chest CT with consolidation and abscess), brain abscess (head MRI with ring-enhancing lesion), pelvic infection (pelvic anatomy with infected endometrium highlighted), and necrotizing soft tissue infection (clinical photo appearance with spreading erythema and crepitus indicators). Panel D: Antibiotic susceptibility chart formatted as stacked horizontal bars - penicillin (large green "effective" bar), metronidazole (large green bar labeled "excellent"), clindamycin (green bar labeled "good penetration"), carbapenems (green bar labeled "broadest coverage"), with comparative MIC values and clinical pearls for each agent.</image>

VI. Actinomyces

Actinomyces species represent a unique group of bacteria that, despite their fungal-sounding name and filamentous growth pattern, are definitively classified as bacteria based on prokaryotic cell structure, antibiotic susceptibility, and ribosomal RNA sequences. These gram-positive organisms demonstrate characteristic branching filamentous morphology that led early microbiologists to classify them with fungi, an error perpetuated in the nomenclature. The genus grows under anaerobic to microaerophilic conditions and requires extended culture periods due to slow replication. Normal flora sites include the oral cavity, particularly around teeth and tonsillar crypts, the gastrointestinal tract throughout its length, and the female genital tract where colonization becomes clinically significant in the context of intrauterine devices.

Clinical actinomycosis manifests in several distinct anatomical forms that share common pathological features despite different presentations. Cervicofacial actinomycosis, colloquially termed "lumpy jaw," represents the most common form, typically arising from dental infection, trauma, or extraction that allows organisms to penetrate normally intact mucosal barriers. Thoracic actinomycosis involves the lungs and chest wall, often presenting with masses that mimic malignancy and characteristically extend through the chest wall to form cutaneous sinuses. Abdominal actinomycosis frequently associates with intrauterine device use or occurs following appendectomy or other abdominal surgery, presenting as slowly enlarging masses that cross tissue planes. Pelvic actinomycosis in IUD users can cause tubo-ovarian abscess and presents diagnostic challenges as it mimics ovarian malignancy on imaging.

The pathognomonic features of actinomycosis include sulfur granules, draining sinuses, and disregard for normal anatomic boundaries. Sulfur granules appear as yellow-white particles within purulent material, representing macroscopic colonies of intertwined Actinomyces filaments surrounded by inflammatory debris; despite the name, they contain no actual sulfur but are named for their color and granular appearance. Draining sinuses develop as chronic infection erodes through soft tissues to the skin surface, creating persistent fistulous tracts that drain purulent material containing sulfur granules. Unlike most infections that remain confined by fascial planes and anatomic boundaries, actinomycosis characteristically crosses tissue planes, spreading from one compartment to another in a manner mimicking malignancy. Actinomycosis rarely occurs as pure infection, with "companion organisms" including Aggregatibacter actinomycetemcomitans frequently co-isolated.

Diagnosis of actinomycosis requires clinical suspicion combined with appropriate specimen collection and processing. The presence of sulfur granules in purulent material, when crushed and stained, reveals characteristic gram-positive branching filaments. Culture requires prolonged anaerobic incubation, often two to three weeks, and may fail if specimens are not properly collected or transported. Histopathological examination shows the characteristic "ray fungus" appearance with radiating filaments at the periphery of granules surrounded by intense neutrophilic inflammation. Treatment requires prolonged high-dose antibiotic therapy, with penicillin remaining the drug of choice administered for 6-12 months to ensure eradication of organisms sequestered within fibrotic tissue. Doxycycline serves as an alternative for penicillin-allergic patients. Surgical intervention, including debridement of involved tissue and removal of IUDs, supplements antibiotic therapy and may be required for bulky disease.

<image>Panel A: Actinomyces cellular structure and morphology - microscopic view showing gram-positive branching filamentous rods, colony morphology resembling "molar tooth" on agar plate, and comparison diagram emphasizing bacterial (not fungal) characteristics including prokaryotic cell wall, lack of true hyphae, and antibiotic sensitivity pattern. Panel B: Clinical forms of actinomycosis shown on human figure - cervicofacial "lumpy jaw" with dental origin and draining sinus (facial profile illustration), thoracic form with chest wall extension (thorax cross-section), abdominal form with IUD association (abdominal CT appearance), and pelvic form mimicking ovarian mass (pelvic MRI appearance). Panel C: Sulfur granule detailed analysis - macroscopic appearance as yellow particles in pus (test tube with purulent material), crushed granule preparation showing radiating filaments, histopathological "ray fungus" appearance with central colony and surrounding inflammation, and formation mechanism showing bacterial colony growth with inflammatory cell accretion. Panel D: Treatment protocol visualization - high-dose penicillin regimen (IV followed by oral with 6-12 month timeline), alternative doxycycline option, surgical indications (IUD removal diagram, debridement of cervicofacial lesion), and treatment response monitoring curve showing slow resolution over months.</image>

VII. Propionibacterium (Cutibacterium) acnes

Cutibacterium acnes, formerly known as Propionibacterium acnes, represents a ubiquitous skin colonizer that occupies sebaceous glands throughout the integument, with highest concentrations on the face, chest, and back where sebaceous activity is greatest. This gram-positive rod demonstrates anaerobic to aerotolerant metabolism and exhibits characteristically slow growth, often requiring prolonged culture incubation of days to weeks before colonies become visible. The recent reclassification from Propionibacterium to Cutibacterium reflects advances in taxonomic understanding, though both names remain in common clinical use. The organism's residence within sebaceous glands provides a protected niche with limited oxygen, supporting anaerobic growth while also positioning it to cause infections associated with surgical procedures involving skin preparation.

The clinical significance of Cutibacterium acnes spans from the extremely common adolescent affliction of acne vulgaris to serious device-associated infections. In acne pathogenesis, C. acnes produces lipases that hydrolyze sebum triglycerides, releasing free fatty acids that irritate follicular epithelium and trigger inflammatory responses. The resulting follicular inflammation, comedone formation, and pustule development constitute the familiar presentation of acne affecting millions of individuals. Far more serious infections involve prosthetic devices and implanted hardware, where C. acnes causes indolent infections presenting months to years after implantation. Shoulder arthroplasty infections demonstrate particular association with C. acnes, reflecting the sebaceous gland density of the shoulder region and the organism's ability to form biofilms on prosthetic surfaces.

Prosthetic joint infection caused by Cutibacterium acnes presents distinctive diagnostic challenges due to its indolent nature and the organism's slow growth. Symptoms include chronic pain and progressive loosening of the prosthesis rather than the acute presentation typical of Staphylococcus infections. The onset may be delayed by months to years following the index procedure, during which the organism proliferates slowly within biofilms on the prosthetic surface. Diagnosis requires high clinical suspicion and submission of multiple tissue samples for prolonged anaerobic culture, as single specimens may yield false-negative results due to low bacterial burden. Treatment typically requires combination of prolonged antibiotic therapy, often with penicillin-class agents, and surgical intervention including hardware removal for cure, as biofilm-associated organisms resist antibiotic eradication without source control.

Distinguishing true Cutibacterium acnes infection from culture contamination presents an important clinical challenge, as this ubiquitous skin organism frequently contaminates blood cultures and tissue specimens despite careful technique. Several factors help differentiate colonization or contamination from true infection. A single positive culture from an otherwise sterile site likely represents contamination, whereas multiple positive cultures from separate specimens suggest true infection. The clinical context matters significantly: C. acnes recovered from a patient with a prosthetic joint and chronic pain likely represents infection, while isolation from a healthy individual's blood culture more probably represents contamination during venipuncture. Time to culture positivity may also provide clues, as contaminants sometimes appear later than true pathogens, though the slow growth of C. acnes limits the utility of this criterion.

<image>Panel A: Cutibacterium acnes anatomy and location - skin cross-section showing sebaceous gland with C. acnes colonies (gram-positive rods illustrated), sebum production pathway, hair follicle relationship, and density map showing highest concentrations on face, chest, and back (body heat map style illustration). Panel B: Acne vulgaris pathogenesis sequence - normal sebaceous gland progressing to C. acnes overgrowth, lipase enzyme cleaving triglycerides to release free fatty acids, inflammatory cell recruitment to follicle, and progression through comedone, papule, and pustule stages with histological correlation. Panel C: Prosthetic joint infection timeline and presentation - shoulder arthroplasty illustration, timeline showing months to years latent period, biofilm formation on prosthetic surface (electron microscopy appearance), clinical presentation with chronic pain and radiographic loosening, and diagnostic approach (multiple tissue samples, prolonged culture). Panel D: Contamination versus true infection decision matrix - comparison table with rows for "number of positive cultures," "clinical context," "growth timing," and "presence of device/surgery," with green checkmarks for infection indicators and red X marks for contamination indicators, and decision pathway flowchart at bottom.</image>

VIII. Clostridium Species (Review)

The genus Clostridium encompasses gram-positive, spore-forming obligate anaerobes that produce some of the most potent toxins known to medicine. The spore-forming capability distinguishes Clostridium from other anaerobic gram-positive rods and confers remarkable environmental persistence, allowing these organisms to survive in soil, dust, and the gastrointestinal tract for extended periods awaiting favorable conditions for germination. The major pathogenic species each cause distinctive clinical syndromes mediated by specific toxins that represent their primary virulence factors. Clostridioides difficile (formerly Clostridium difficile) causes antibiotic-associated colitis through toxins A and B that damage intestinal epithelium. Clostridium perfringens produces alpha-toxin, a lecithinase that destroys cell membranes and causes the characteristic gas gangrene presentation of myonecrosis.

Clostridium tetani causes tetanus through production of tetanospasmin, one of the most potent neurotoxins known, while Clostridium botulinum produces botulinum toxin that causes descending flaccid paralysis. Beyond these classic pathogens, several other Clostridium species cause important clinical disease that clinicians must recognize. Clostridium septicum demonstrates a striking association with underlying gastrointestinal malignancy, particularly colon cancer, and causes spontaneous (non-traumatic) gas gangrene in neutropenic patients. The mechanism involves tumor-induced mucosal disruption that allows C. septicum translocation from the bowel lumen into tissues where it causes rapidly progressive myonecrosis. Recognition of C. septicum bacteremia or gas gangrene should prompt colonoscopy to evaluate for occult malignancy even in patients without gastrointestinal symptoms.

Clostridium sordellii causes a particularly fulminant toxic shock-like syndrome associated with postpartum infection, post-abortion procedures, and wound infections. The clinical presentation differs from typical sepsis, characteristically featuring absence of fever despite profound systemic illness, profound leukocytosis with white blood cell counts often exceeding 50,000 cells per microliter, and refractory hypotension. The mortality rate is extremely high, often exceeding 75%, even with aggressive intensive care support. Cases have been associated with medical abortions using mifepristone and misoprostol, though the infection remains rare. The organism produces lethal toxin and hemorrhagic toxin that cause massive capillary leak and cardiovascular collapse through mechanisms similar to other clostridial toxins but with distinctive clinical features.

Clostridium tertium represents an unusual Clostridium species that demonstrates aerotolerance, capable of growing on aerobic culture and thus potentially misidentified as other organisms including Lactobacillus. This organism primarily affects neutropenic patients, often those with hematologic malignancies, where it can cause bacteremia and soft tissue infection. Critically for treatment selection, C. tertium demonstrates intrinsic resistance to metronidazole, the otherwise excellent agent against anaerobes, requiring selection of alternative agents such as penicillin, vancomycin, or carbapenems. The combination of aerotolerance and metronidazole resistance makes C. tertium a diagnostic and therapeutic challenge that requires laboratory awareness and clinical vigilance.

<image>Panel A: Clostridium species comparison chart - five major species (C. difficile, C. perfringens, C. tetani, C. botulinum, C. septicum) arranged in columns, each showing spore morphology illustration, primary toxin name and mechanism, clinical disease produced, and distinctive clinical feature (pseudomembrane, gas gangrene, risus sardonicus, descending paralysis, malignancy association). Panel B: Clostridium septicum and malignancy connection - colon cross-section showing colorectal tumor with mucosal disruption, C. septicum translocation pathway from lumen to tissue, resulting spontaneous gas gangrene in limb (clinical appearance with crepitus), and diagnostic algorithm emphasizing colonoscopy for all C. septicum infections. Panel C: Clostridium sordellii toxic shock presentation - comparison panel showing typical sepsis (fever, elevated WBC) versus C. sordellii syndrome (absent fever, profound leukocytosis >50K, refractory hypotension), clinical context icons (postpartum, post-abortion, wound), and survival curve showing high mortality despite treatment. Panel D: Clostridium tertium unique features - aerotolerance demonstration (growth on aerobic plate), metronidazole resistance mechanism (crossed-out metronidazole molecule), typical patient population (neutropenic patient icon with chemo bag), and effective antibiotic alternatives (penicillin, vancomycin, carbapenems with green checkmarks).</image>

IX. Diagnosis of Anaerobic Infections

Proper specimen collection represents the critical first step in successful anaerobic diagnosis, as these fastidious organisms are easily killed by oxygen exposure or overgrown by contaminating aerobes. The fundamental principle involves avoiding contamination with normal flora from mucosal surfaces that harbor abundant anaerobes, as culture of such mixed populations prevents meaningful interpretation. Aspirated material from normally sterile sites, surgically obtained tissue samples, and blood cultures drawn properly represent ideal specimens for anaerobic culture. Anaerobic transport media containing reducing agents must be used, with specimens transported to the laboratory rapidly to minimize oxygen exposure during transit. Specimen volume matters, with larger samples more likely to yield positive cultures due to greater bacterial numbers and protection of organisms within the specimen mass.

Certain specimen types should generally not be submitted for anaerobic culture due to inevitable contamination with normal flora. Swabs from wounds or mucosal surfaces collect both pathogens and colonizing organisms, preventing meaningful interpretation of culture results. Sputum represents expectorated material contaminated with oral flora containing numerous anaerobic species, making anaerobic culture inappropriate; protected bronchial specimens or lung tissue provide suitable alternatives for suspected pulmonary anaerobic infection. Voided urine, stool samples (except for C. difficile testing), and vaginal swabs similarly contain normal flora that preclude useful anaerobic culture. When surface sampling is unavoidable, aspiration of deeper material or tissue biopsy provides superior specimens.

Laboratory methods for anaerobic culture require specialized equipment and expertise not universally available at all facilities. Anaerobic chambers or jars create the oxygen-free environment essential for growth, using various methods including hydrogen-carbon dioxide gas mixtures with palladium catalysts to remove residual oxygen. Specialized media including Brucella agar supplemented with hemin and vitamin K, KVLB (kanamycin-vancomycin laked blood) for selective recovery of Bacteroides, and CCFA (cycloserine-cefoxitin-fructose agar) for C. difficile support growth of specific organisms. Incubation periods of 48-72 hours minimum are required, with some organisms requiring even longer culture times. Identification traditionally relied on biochemical testing and gas chromatography analysis of metabolic products, but MALDI-TOF mass spectrometry has revolutionized anaerobic identification, providing rapid and accurate results from isolated colonies.

Several laboratory findings provide indicators of anaerobic infection even before culture results become available. Foul odor noted when specimens are opened strongly suggests anaerobic organisms, as they produce malodorous short-chain fatty acids during metabolism. Gas production visualized as bubbles in liquid specimens or tissue specimens reflects anaerobic metabolic pathways producing carbon dioxide, hydrogen, and methane. Fluorescence under ultraviolet light, particularly red fluorescence, indicates the presence of Prevotella or Porphyromonas species due to porphyrin pigment production. Black pigmentation of colonies identifies Prevotella melaninogenica and Porphyromonas species. Antibiotic susceptibility testing for anaerobes is not routinely performed due to technical complexity, with empiric therapy guided by likely organisms based on infection site; testing should be reserved for treatment failures or serious infections not responding to standard therapy.

<image>Panel A: Specimen collection quality comparison - split panel showing "good specimens" (aspiration of abscess with syringe, surgical tissue in sterile container, blood culture bottles) with green checkmarks versus "poor specimens" (surface swab, sputum cup, voided urine cup) with red X marks, and "why" explanation boxes noting contamination with normal flora. Panel B: Anaerobic transport and processing workflow - specimen placed in anaerobic transport tube (with reducing agent indicator color), time clock showing rapid transport importance, laboratory processing in anaerobic chamber (clear dome with glove ports), and plating onto multiple selective media (Brucella agar, KVLB, CCFA plates). Panel C: Colony identification features - four-quadrant image showing characteristic appearances - foul odor (wavy lines over plate with nose icon), gas bubbles in liquid culture, red fluorescence under UV light (Prevotella/Porphyromonas), and black-pigmented colonies (P. melaninogenica), with organism identification flow from each finding. Panel D: MALDI-TOF identification process - bacterial colony transferred to target plate, laser ionization diagram, mass spectrum with characteristic peaks, database matching to organism identification, and time comparison showing minutes versus days for traditional biochemical methods.</image>

X. Treatment Principles

Antibiotic selection for anaerobic infections requires knowledge of the spectrum of available agents, as the unusual metabolic characteristics of anaerobes confer both intrinsic resistances and unique susceptibilities. Metronidazole represents the cornerstone of anaerobic therapy, demonstrating excellent bactericidal activity against most obligate anaerobes through formation of toxic metabolites that damage DNA after reduction by anaerobic electron transport systems. Importantly, metronidazole lacks activity against Actinomyces and Propionibacterium (Cutibacterium), microaerophilic organisms that do not sufficiently reduce the prodrug to its active form. Clindamycin covers most anaerobes with excellent tissue penetration, though increasing resistance among Bacteroides fragilis group organisms limits its empiric use. Carbapenems provide the broadest anaerobic coverage and represent reliable empiric choices for serious mixed infections.

Beta-lactam/beta-lactamase inhibitor combinations offer excellent anaerobic coverage while addressing the beta-lactamase production common among Bacteroides species. Piperacillin-tazobactam and ampicillin-sulbactam effectively treat most anaerobic infections and provide concomitant aerobic coverage useful for mixed infections. Penicillin alone remains effective against mouth anaerobes, Clostridium species, and anaerobic gram-positive cocci, but cannot be relied upon for Bacteroides fragilis due to beta-lactamase production. Chloramphenicol demonstrates excellent anaerobic activity but is rarely used systemically due to toxicity concerns including aplastic anemia. Tigecycline, a glycylcycline antibiotic, provides useful anaerobic coverage as part of its broad spectrum.

Several antibiotic classes demonstrate poor or absent activity against anaerobes and should not be relied upon for therapy of anaerobic infections. Aminoglycosides require oxygen-dependent active transport for bacterial uptake and are completely ineffective against obligate anaerobes; this principle provides the clinical clue that aminoglycoside failure suggests anaerobic infection. Most fluoroquinolones lack reliable anaerobic activity, with only moxifloxacin demonstrating useful activity against some anaerobes. Aztreonam, the monobactam antibiotic, lacks activity against gram-positive organisms and anaerobes entirely. Trimethoprim-sulfamethoxazole provides poor anaerobic coverage and should not be used for these infections.

Successful treatment of anaerobic infections extends beyond antibiotic selection to include essential adjunctive measures addressing the source of infection. Surgical drainage remains the cornerstone of abscess management, as antibiotics cannot sterilize walled-off collections regardless of in vitro susceptibility; the acidic, hypoxic environment within abscesses impairs antibiotic activity, and the fibrous capsule prevents adequate drug penetration. Debridement of necrotic tissue removes the substrate supporting continued bacterial growth and eliminates the ischemic conditions favoring anaerobic proliferation. Source control measures including removal of foreign bodies and intrauterine devices eliminate the nidus of infection. Hyperbaric oxygen therapy serves as an adjunctive measure for gas gangrene, raising tissue oxygen tension to levels inhibitory for Clostridium while supporting wound healing and immune function, though it does not replace surgical debridement as definitive therapy.

<image>Panel A: Antibiotic spectrum chart for anaerobes - horizontal bar graph showing each antibiotic class (metronidazole, clindamycin, carbapenems, piperacillin-tazobactam, penicillin) with coverage bars for different organism groups (Bacteroides, oral anaerobes, Clostridium, Actinomyces), with gaps showing limitations (metronidazole gap for Actinomyces, penicillin gap for B. fragilis). Panel B: Ineffective antibiotics mechanism explanations - aminoglycosides (diagram showing oxygen-dependent transport blocked in anaerobic conditions), fluoroquinolones (minimal activity bar), aztreonam (no gram-positive/anaerobic coverage shown as gaps), TMP-SMX (poor coverage indicated), with clinical pearl: "Aminoglycoside failure = think anaerobes." Panel C: Abscess physiology explaining antibiotic failure - cross-section showing low pH zone, hypoxic center, thick fibrous capsule, and antibiotic molecule unable to penetrate, with comparison to same abscess post-drainage showing resolution. Panel D: Adjunctive treatment modalities - four-quadrant illustration showing surgical drainage (percutaneous catheter placement), debridement (surgical removal of necrotic tissue), source control (IUD removal, foreign body extraction), and hyperbaric oxygen therapy (patient in chamber with O2 delivery diagram and "adjunctive only" label).</image>

Summary

• Anaerobes are organisms that cannot utilize oxygen for metabolism; obligate anaerobes are killed by atmospheric oxygen while aerotolerant organisms survive brief exposure
• Normal anaerobic flora colonizes the oral cavity (Fusobacterium, Prevotella, Actinomyces), colon (Bacteroides outnumber aerobes 1000:1), female genital tract, and skin
• Clinical clues to anaerobic infection include foul odor, gas in tissues, abscess formation, proximity to mucosal surfaces, aminoglycoside failure, and sulfur granules
• Bacteroides fragilis is the most common anaerobic pathogen, causing intra-abdominal abscesses; treatment includes metronidazole, carbapenems, or beta-lactam/beta-lactamase inhibitors plus surgical drainage
• Fusobacterium necrophorum causes Lemierre syndrome, characterized by pharyngitis progressing to internal jugular vein thrombophlebitis and septic pulmonary emboli
• Actinomyces causes chronic infections with sulfur granules and draining sinuses; treatment requires prolonged high-dose penicillin (6-12 months)
• Cutibacterium acnes causes acne vulgaris and prosthetic joint infections, particularly shoulder arthroplasty; slow growth complicates diagnosis
• Clostridium septicum is associated with underlying GI malignancy and causes spontaneous gas gangrene; patients require colonoscopy evaluation
• Proper specimen collection (avoiding surface contamination, anaerobic transport, adequate volume) is essential for successful anaerobic culture
• Treatment principles include selecting appropriate antibiotics (metronidazole, carbapenems, clindamycin), avoiding ineffective agents (aminoglycosides, fluoroquinolones), and ensuring surgical source control

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown